Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
Adobe Names Anil Chakravarthy CEO as AI Push Accelerates 
Anthropic Nears $15 Billion Credit Deal Ahead of IPO 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab 
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada 
Xiaomi Shares Jump on Europe EV Expansion Plan 
ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
OpenAI Nears Astra AI Model Launch With Safety Focus 
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up 
Lynas Rare Earths Shares Rise After Takeover Talks Revealed 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Shein Shares Drop 5% After Weak Hong Kong IPO Debut 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
South Korea, US Discuss Chip Investments Amid Tariff Plans 
Add as a preferred source on Google
SAN DIEGO and TORONTO, March 06, 2018 -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, and Gregory K. Chow, Senior Vice President and Chief Financial Officer, will participate at the upcoming conferences:
- Cowen and Company 38th Annual Healthcare Conference
| Time: | 12:00 p.m. EDT | ||
| Date: | Monday, March 12, 2018 | ||
| Location: | The Boston Marriott Copley Place, Boston, MA | ||
| Live webcast: | http://wsw.com/webcast/cowen46/apto/ | ||
- 30th Annual ROTH Conference
| Time: | 9:30 a.m. PDT | ||
| Date: | Tuesday, March 13, 2018 | ||
| Location: | The Ritz Carlton, Laguna Niguel, CA | ||
| Live webcast: | http://wsw.com/webcast/roth32/apto/ | ||
- 2018 B. Riley & Co. China Healthcare Investment Partnering Symposium
| Time: | 11:30 a.m. CST (China Standard Time) | ||
| Date: | Friday, March 16, 2018 | ||
| Location: | The Intercontinental Hotel, Hangzhou, People’s Republic of China | ||
| Live webcast: | http://wsw.com/webcast/brileyco20/apto/ | ||
- Oppenheimer 28th Annual Healthcare Conference
| Time: | 8:00 a.m. EDT | ||
| Date: | Wednesday, March 21, 2018 | ||
| Location: | The Westin Grand Central, New York, NY | ||
| Live webcast: | https://veracast.com/webcasts/opco/healthcare2018/76201109497.cfm | ||
The audio webcasts can also be accessed through the Aptose website at www.aptose.com and will be archived shortly after the live event and available for 90 days.
About Aptose Biosciences
Aptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology. Aptose is advancing new therapeutics focused on novel cellular targets on the leading edge of cancer. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. For further information, please visit www.aptose.com.
For further information, please contact:
Aptose Biosciences
Greg Chow, CFO
647-479-9828
Email: [email protected]
| SMP Communications Susan Pietropaolo 201-923-2049 [email protected] | LifeSci Advisors Michael Wood Managing Director 646-597-6983 [email protected] |
